The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
Patil, Tejas, Staley, Alyse, Nie, Yunan, Sakamoto, Mandy, Stalker, Margaret, Jurica, James M., Koehler, Kenna, Cass, Amanda, Kuykendall, Halle, Schmitt, Emily, Filar, Emma, Reventaite, Evelina, Davies, Kurt D., Nijmeh, Hala, Haag, Mary, Yoder, Benjamin A., Bunn, Paul A., Schenk, Erin L., Aisner, Dara L., Iams, Wade T., Marmarelis, Melina E., Camidge, D. Ross
Published in JTO clinical and research reports (01.02.2024)
Published in JTO clinical and research reports (01.02.2024)
Get full text
Journal Article
CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhibitor Resistance in Patient With EGFR-Mutated NSCLC With CNS Progression
Jurica, James M, Carsten, Billie, Balakhani, Sudabeh, Haag, Mary M, Aisner, Dara L, Camidge, D Ross
Published in Clinical lung cancer (01.01.2024)
Published in Clinical lung cancer (01.01.2024)
Get full text
Journal Article
Approach to radiation therapy in the Jehovah’s Witness patient: An overview
Jurica, James M., Messer, Jay A., Teh, Bin S., Butler, Brian E., Farach, Andrew M.
Published in Reports of practical oncology and radiotherapy (01.11.2020)
Published in Reports of practical oncology and radiotherapy (01.11.2020)
Get full text
Journal Article